NCT03228693View on ClinicalTrials.gov

Gene Expression and Biomarker Profiling of Keloid Skin

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

September 2, 2021

Study Completion Date

January 31, 2023

Conditions
KeloidKeloid of Ear LobeHealthy Adults
Interventions
PROCEDURE

Biopsy and/or triamcinolone injection

Subjects will have their blood drawn during the first study visit. Subsequently, a punch biopsy and/or triamcinolone injection will be given based on group timeline.

PROCEDURE

Excisional Biopsy

Complete excision of an earlobe keloid will be taken.

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine Department of Dermatology, Chicago

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Northwestern University

OTHER

NCT03228693 - Gene Expression and Biomarker Profiling of Keloid Skin | Biotech Hunter | Biotech Hunter